- Home
- RMAX vs QTRX Comparison
RMAX vs QTRX Comparison
Compare RMAX & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMAX | QTRX |
|---|---|---|
| Founded | 1973 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.4M | 160.0M |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RMAX | QTRX |
|---|---|---|
| Price | $10.07 | $4.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $11.40 | $6.00 |
| AVG Volume (30 Days) | 272.1K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $195,929,000.00 | $37,632,000.00 |
| Revenue This Year | $2.62 | $25.49 |
| Revenue Next Year | $1.24 | $10.04 |
| P/E Ratio | $16.43 | ★ N/A |
| Revenue Growth | 11.13 | ★ 64.52 |
| 52 Week Low | $5.46 | $2.40 |
| 52 Week High | $11.62 | $8.77 |
Technical Indicators
Market Signals| Indicator | RMAX | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 71.68 |
| Support Level | $8.77 | $4.50 |
| Resistance Level | $11.51 | $6.27 |
| Average True Range (ATR) | 0.37 | 0.36 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 91.04 | 100.00 |
Price Performance
Historical ComparisonAbout RMAX RE/MAX Holdings Inc.
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.